Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5301
StepStone Group
STEP
$3.82B
| $1.91M | ﹤0.01% |
48,080
-410,340
| -90% | -$11.9M |
|
5302
Associated Banc-Corp
ASB
$5.91B
| $1.91M | ﹤0.01% |
112,039
-722,535
| -87% | -$11M |
|
|
ESPR
5303
PUT
DELISTED
Esperion Therapeutics
ESPR
| $1.91M | ﹤0.01% |
73,500
+48,400
| +193% | +$1.45M |
|
5304
CALL
Red Robin
RRGB
$152M
| $1.91M | ﹤0.01% |
99,400
+8,400
| +9% | +$141K |
|
|
CHNG
5305
PUT
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $1.91M | ﹤0.01% |
102,400
+18,000
| +21% | +$296K |
|
5306
iShares Global REIT ETF
REET
$5.11B
| $1.91M | ﹤0.01% |
79,746
-142,435
| -64% | -$3.21M |
|
|
ZYXI
5307
DELISTED
Zynex
ZYXI
| $1.91M | ﹤0.01% |
155,850
+25,092
| +19% | +$326K |
|
5308
PUT
United Microelectronic
UMC
$46.9B
| $1.9M | ﹤0.01% |
225,900
+194,100
| +610% | +$1.27M |
|
5309
CALL
Brookfield
BN
$108B
| $1.9M | ﹤0.01% |
86,137
+10,650
| +14% | +$213K |
|
5310
PUT
Laureate Education
LAUR
$5.28B
| $1.9M | ﹤0.01% |
130,600
+55,100
| +73% | +$778K |
|
|
GTHX
5311
PUT
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.9M | ﹤0.01% |
105,700
+8,800
| +9% | +$131K |
|
5312
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.9B
| $1.9M | ﹤0.01% |
+13,365
| New | +$1.72M |
|
5313
First Citizens BancShares
FCNCA
$25.3B
| $1.9M | ﹤0.01% |
3,309
-4,506
| -58% | -$2.27M |
|
5314
PUT
Charles River Laboratories
CRL
$12.8B
| $1.9M | ﹤0.01% |
7,600
-1,500
| -16% | -$357K |
|
5315
PUT
Precigen
PGEN
$2.59B
| $1.9M | ﹤0.01% |
186,100
+102,400
| +122% | +$664K |
|
5316
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.9B
| $1.9M | ﹤0.01% |
42,361
-100,300
| -70% | -$4.14M |
|
5317
Innovator US Equity Buffer ETF June
BJUN
$322M
| $1.9M | ﹤0.01% |
60,812
+1,065
| +2% | +$32.4K |
|
|
5318
United Microelectronic
UMC
$46.9B
| $1.9M | ﹤0.01% |
224,968
-109,661
| -33% | -$715K |
|
5319
State Street SPDR S&P Global Dividend ETF
WDIV
$281M
| $1.9M | ﹤0.01% |
31,420
-19,207
| -38% | -$1.11M |
|
|
TSC
5320
DELISTED
TriState Capital Holdings, Inc.
TSC
| $1.9M | ﹤0.01% |
109,011
+2,891
| +3% | +$43.5K |
|
5321
PUT
Momentus
MNTS
$92.7M
| $1.9M | ﹤0.01% |
+8
| New | +$1.26M |
|
5322
AeroVironment
AVAV
$9.45B
| $1.89M | ﹤0.01% |
21,787
-54,481
| -71% | -$4.37M |
|
5323
PUT
Westlake Corp
WLK
$9.9B
| $1.89M | ﹤0.01% |
23,200
-6,600
| -22% | -$493K |
|
5324
PUT
ProShares VIX Short-Term Futures ETF
VIXY
$183M
| $1.89M | ﹤0.01% |
1,720
-920
| -35% | -$1.22M |
|
5325
Energizer
ENR
$1.55B
| $1.89M | ﹤0.01% |
44,733
+30,288
| +210% | +$1.28M |
|
Similar funds
Citadel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.
- Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
- Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.